Flucytosine is another antifungal medicine. It works by stopping the growth of certain types of fungi. It's often used in combination with other antifungal drugs to treat serious fungal infections, especially in people with weakened immune systems. It helps fight the infection and prevent it from getting worse.
Every report comes from a Lived member, sent anonymously.
Have you tried Flucytosine for Cryptococcal Meningitis?
Flucytosine, sold in the US as Ancobon and as generic capsules, is a prescription antifungal medicine reserved for serious infections caused by two kinds of yeast: Candida and Cryptococcus. It is not used for everyday yeast infections such as vaginal thrush or athlete's foot. Its most important use today is cryptococcal meningitis, a fungal infection of the lining of the brain and spinal cord that mainly affects people with weakened immune systems, especially people with advanced HIV. It is also used for serious Candida infections of the bloodstream, heart valves (endocarditis) or urinary tract, and for some cryptococcal lung infections. Flucytosine is almost always given in combination with amphotericin B, a powerful intravenous antifungal, and in some newer regimens with fluconazole as well. Fungi can quickly become resistant to flucytosine when it is used on its own, so it is not meant to be a stand-alone treatment.
Fungal cells absorb flucytosine and convert it, using an enzyme that human cells largely lack, into fluorouracil, a compound that disrupts how the fungus makes RNA and DNA. Without working genetic machinery, the fungus cannot make proteins or multiply properly. Paired with amphotericin B, which damages the fungal cell's outer membrane, flucytosine clears the infection faster than either drug achieves alone. It also passes well into the fluid around the brain and spinal cord, which is why it is valuable for meningitis. In a large trial in people with HIV and cryptococcal meningitis, adding flucytosine to amphotericin B cleared the fungus from spinal fluid faster and improved survival compared with amphotericin B by itself.
Flucytosine comes as capsules taken by mouth, in divided doses every 6 hours, around the clock. The total daily amount is calculated from body weight, and the course is usually short: in common regimens for cryptococcal meningitis it lasts about one to two weeks during the initial, intensive phase of treatment, often in the hospital. Taking the capsules a few at a time over about 15 minutes can reduce nausea and vomiting. Because the kidneys clear the drug, people with reduced kidney function start at a lower dose, and the dose may be changed during treatment as kidney tests change. Keeping to the 6-hour schedule matters; ask the care team what to do about a missed dose rather than doubling up.
Nausea, vomiting, diarrhea, stomach pain and loss of appetite are the most common side effects. Rash, itching and increased sensitivity to sunlight can also occur. Less often, people experience confusion, hallucinations, headache or dizziness. The most serious risk is suppression of the bone marrow, which makes blood cells. It can cause low white cell counts (raising infection risk), low platelets (raising bleeding risk) and anemia, and in people with weakened immune systems it can be permanent or fatal. Liver injury can also occur. Fever, chills or mouth sores, unusual bruising or bleeding, or yellowing of the skin or eyes should be reported to the care team right away. Regular blood tests are designed to catch these problems before symptoms appear.
Flucytosine carries a boxed warning, the FDA's most prominent caution: it must be used with extreme care in people with impaired kidney function, and everyone taking it needs close monitoring of blood counts, kidney function and liver function. Amphotericin B, its usual partner, can itself strain the kidneys, so the two are watched together. Flucytosine should not be taken by people known to have complete DPD (dihydropyrimidine dehydrogenase) deficiency, an inherited lack of the enzyme that breaks down fluorouracil. Even partial DPD deficiency can lead to severe toxicity, such as mouth sores, diarrhea, very low white cell counts and nerve problems. Anyone told they have DPD deficiency, for example after a severe reaction to the cancer drug fluorouracil, should tell the care team. Other medicines that suppress the bone marrow, recent chemotherapy or radiation, and drugs that reduce kidney function all add to the risk. Cytarabine, a chemotherapy drug, can block flucytosine's antifungal effect. Flucytosine caused birth defects in animal studies and has not been well studied in pregnancy, so it is used during pregnancy only when the benefit clearly justifies the risk; breastfeeding is generally paused or the drug avoided.
Flucytosine is usually one part of a carefully planned, intensive treatment, often started in the hospital. Blood counts and kidney and liver tests are checked frequently, and in many centers the amount of flucytosine in the blood is measured as well, since levels that stay too high are linked to more side effects. Potassium is also checked before and during treatment. Once the initial phase ends, flucytosine is stopped. For cryptococcal meningitis, treatment then continues with fluconazole, an antifungal pill, typically for about eight weeks at a higher dose and often longer at a lower dose, to keep the infection from coming back. How well someone does depends heavily on how severe the infection was and on their underlying health.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Flucytosine, what you've noticed, or ask the community a question.